Sphera Funds Management Ltd. Acadia Pharmaceuticals Inc Put Options Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
352Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.05 Billion8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$371 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$294 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$208 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$171 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.95B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...